Literature DB >> 7153881

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

L B Sheiner, S L Beal.   

Abstract

One may attempt to individualize drug dosage by estimating an individual's pharmacokinetic parameters. Information useful for this purpose consists of certain population pharmacokinetic parameters (notably those describing the typical relationship between dosage and drug concentrations) and also measured drug concentrations from the individual of concern. Both types of information should be used. A (Bayesian) method that does so has been described in the pharmacokinetic literature. In this report an implementation of the Bayesian method that is readily adapted to a microcomputer is presented. Using simulated data it is compared with two other methods proposed by others, for estimating individual theophylline clearances. Both previously suggested methods are shown to be less precise than the Bayesian method: their typical error magnitudes are 20-70% larger.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153881     DOI: 10.1002/jps.2600711209

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  86 in total

1.  Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.

Authors:  B Vadher; D L Patterson; M Leaning
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.

Authors:  J W Mandema; D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1992-10

Review 3.  Covariate pharmacokinetic model building in oncology and its potential clinical relevance.

Authors:  Markus Joerger
Journal:  AAPS J       Date:  2012-01-25       Impact factor: 4.009

Review 4.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 5.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

6.  Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.

Authors:  Johannes H Proost; Douglas J Eleveld
Journal:  Pharm Res       Date:  2006-11-07       Impact factor: 4.200

Review 7.  The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.

Authors:  Grant H Skrepnek
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

8.  Population pharmacokinetics: theory and practice.

Authors:  L Aarons
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

9.  A Bayesian dose-individualization method for warfarin.

Authors:  Daniel F B Wright; Stephen B Duffull
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

Review 10.  Population pharmacokinetics. Theory and clinical application.

Authors:  B Whiting; A W Kelman; J Grevel
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.